SCN1A and Dravet syndrome: In conclusion, our results indicate that to better interpret the pathogenic impact of missense changes in SCN1A in the context of the molecular diagnosis of patients with DS, the use of multimodal analysis seems to be the best approach, since no single method can unequivocally classify all variants found.